Pukhal'skiĭ A L, Mezhneva A P, Pevnitskiĭ L A
Biull Eksp Biol Med. 1988 Feb;105(2):196-8.
A method of quantitative evaluation of lymphocytes' sensitivity to the antiproliferative effect of the alkylating drugs has been developed. Chlorbutin, mafosfamide (Asta Z 7654) and "active" metabolites of cyclophosphamide were studied. This research allowed to distinguish more sensitive strains (DBA/2 and C57BL/6) and those with low sensitivity (BALB/c and CC57BR). These differences do not depend on proliferation reaction, neither on the type of alkylating drugs nor haplotypes H-2.
已开发出一种定量评估淋巴细胞对烷化剂抗增殖作用敏感性的方法。研究了氯布替林、马磷酰胺(Asta Z 7654)和环磷酰胺的“活性”代谢产物。该研究能够区分出更敏感的品系(DBA/2和C57BL/6)以及低敏感性的品系(BALB/c和CC57BR)。这些差异既不取决于增殖反应,也不取决于烷化剂的类型或H-2单倍型。